BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6735502)

  • 1. Restoration of ultrafiltration capacity of peritoneal membrane in patients on CAPD.
    Bazzato G; Coli U; Landini S; Lucatello S; Fracasso A; Righetto F; Scanferla F; Morachiello P
    Int J Artif Organs; 1984 Mar; 7(2):93-6. PubMed ID: 6735502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Permanent loss of ultrafiltration capacity of the peritoneum in long-term peritoneal dialysis: an epidemiological study.
    Slingeneyer A; Canaud B; Mion C
    Nephron; 1983; 33(2):133-8. PubMed ID: 6835460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritoneal rest may successfully recover ultrafiltration in patients who develop peritoneal hyperpermeability with time on continuous ambulatory peritoneal dialysis.
    Rodrigues A; Cabrita A; Maia P; Guimarães S
    Adv Perit Dial; 2002; 18():78-80. PubMed ID: 12402593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between malnutrition-inflammation syndrome and ultrafiltration volume in continuous ambulatory peritoneal dialysis patients.
    Tinroongroj N; Jittikanont S; Lumlertgul D
    J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S94-100. PubMed ID: 22043574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous venous-venous hemofiltration for the treatment of fluid overload in continuous ambulatory peritoneal dialysis patients.
    Giangrande A; Cantù P; Limido A; Allaria P; Brambilla Pisoni I
    Blood Purif; 1985; 3(4):187-91. PubMed ID: 3833261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating Hyponatremia in Non-Diabetic Uremic Patients on Peritoneal Dialysis.
    Yan MT; Cheng CJ; Wang HY; Yang CS; Peng SJ; Lin SH
    Perit Dial Int; 2016; 36(2):196-204. PubMed ID: 26374835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pulmonary function in uremic patients treated with continuous ambulatory peritoneal dialysis (CAPD)].
    Gómez Fernández P; Miguel Alonso JL; Sánchez Agudo L; Calatrava JM; Conesa J; Sánchez Sicilia L
    Med Clin (Barc); 1982 Sep; 79(5):219-23. PubMed ID: 7144303
    [No Abstract]   [Full Text] [Related]  

  • 8. Ultrafiltration with icodextrins in continuous ambulatory peritoneal dialysis and automated peritoneal dialysis.
    Neri L; Viglino G; Cappelletti A; Gandolfo C; Cavalli PL
    Adv Perit Dial; 2000; 16():174-6. PubMed ID: 11045287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal change in peritoneal membrane function with continuous ambulatory peritoneal dialysis (CAPD) after peritonitis episodes.
    Chen JB; Pan HH; Lee CH; Chien YS; Lee CT; Liu TT; Lam KK; Hsu KT
    Chang Gung Med J; 2004 Jan; 27(1):29-34. PubMed ID: 15074887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the effect of uremia on peritoneal permeability in an experimental model of continuous ambulatory peritoneal dialysis in anephric rats.
    Pawlaczyk K; Kuzlan-Pawlaczyk M; Wieczorowska-Tobis K; Polubinska A; Breborowicz A; Oreopoulos D
    Adv Perit Dial; 1999; 15():32-5. PubMed ID: 10682068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous ambulatory peritoneal dialysis (CAPD).
    Swartz RD
    Compr Ther; 1983 Aug; 9(8):54-60. PubMed ID: 6617129
    [No Abstract]   [Full Text] [Related]  

  • 12. A detailed analysis of sodium removal by peritoneal dialysis: comparison with predictions from the three-pore model of membrane function.
    Aanen MC; Venturoli D; Davies SJ
    Nephrol Dial Transplant; 2005 Jun; 20(6):1192-200. PubMed ID: 15827048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneal clearances, protein losses and ultrafiltration in diabetic patients after four years on CAPD.
    Coronel F; Tornero F; Macia M; Sánchez A; De Oleo P; Naranjo P; Barrientos A
    Adv Perit Dial; 1991; 7():35-8. PubMed ID: 1680453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strict volume control normalizes hypertension in peritoneal dialysis patients.
    Günal AI; Duman S; Ozkahya M; Töz H; Asçi G; Akçiçek F; Basçi A
    Am J Kidney Dis; 2001 Mar; 37(3):588-93. PubMed ID: 11228184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of advanced glycation end products and growth factors in peritoneal dysfunction in CAPD patients.
    Nakamura S; Tachikawa T; Tobita K; Miyazaki S; Sakai S; Morita T; Hirasawa Y; Weigle B; Pischetsrieder M; Niwa T
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S61-7. PubMed ID: 12612955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation and management of ultrafiltration failure in CAPD.
    Mactier RA
    Adv Perit Dial; 1991; 7():57-62. PubMed ID: 1680458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium removal and peritoneal dialysis modalities: no differences with optimal prescription of icodextrin.
    Fourtounas C; Dousdampanis P; Hardalias A; Vlachojannis JG
    Artif Organs; 2013 Jul; 37(7):E107-13. PubMed ID: 23461737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal changes of peritoneal function calculated by personal dialysis capacity in a patient after long-term continuous ambulatory peritoneal dialysis.
    Nakamoto H; Takane H; Sugahara S; Kanno Y; Okada H; Yamamoto T; Suzuki H
    Adv Perit Dial; 2003; 19():97-102. PubMed ID: 14763042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exfoliated mesothelial cell and CA-125 in automated peritoneal dialysis (APD) and continuous ambulatory peritoneal dialysis (CAPD) patients.
    Kanjanabuch T; Puttipittayathorn N; Leelahavanichkul A; Lieusuwan S; Katavetin P; Mahatanan N; Sriudom K; Chirananthavat T; Thongbor N; Eiam-Ong S
    J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S119-25. PubMed ID: 22043578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritoneal resting is beneficial in peritoneal hyperpermeability and ultrafiltration failure.
    de Alvaro F; Castro MJ; Dapena F; Bajo MA; Fernandez-Reyes MJ; Romero JR; Jimenez C; Miranda B; Selgas R
    Adv Perit Dial; 1993; 9():56-61. PubMed ID: 8105963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.